{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:44:18Z","timestamp":1782351858134,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.clinthera.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,6,10]],"date-time":"2012-06-10T08:29:30Z","timestamp":1339316970000},"page":"1314-1323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort"],"prefix":"10.1016","volume":"34","author":[{"given":"Bryan T.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Tibbetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Neuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"W. Michael","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.05.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib2","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2006.07.004","article-title":"Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999\u20132005)","volume":"56","author":"Deshpande","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/AAC.01143-06","article-title":"Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamases","volume":"51","author":"Moland","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib5","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.00158-08","article-title":"Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States","volume":"52","author":"Endimiani","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jinf.2009.01.010","article-title":"Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)","volume":"58","author":"Maltezou","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.clinthera.2012.05.002_bib7","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1128\/AAC.00387-11","article-title":"Comparative effectiveness of aminoglycosides, polymixin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine","volume":"55","author":"Satlin","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib8","series-title":"M7-A7, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically","year":"2006"},{"key":"10.1016\/j.clinthera.2012.05.002_bib9","series-title":"M100-S16, Performance Standards for Antimicrobial Susceptibility Testing","year":"2006"},{"key":"10.1016\/j.clinthera.2012.05.002_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/JCM.02123-08","article-title":"Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility","volume":"47","author":"Marschall","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib12","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/jcm.33.8.2141-2144.1995","article-title":"Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR","volume":"33","author":"Del Vecchio","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib13","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1128\/JCM.00690-06","article-title":"Blinded comparison of repetitive-sequence PCR and multilocus sequence typing for genotyping methicillin-resistant Staphylococcus aureus isolates from a children's hospital in St. Louis, Missouri","volume":"44","author":"Liao","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ucl.2007.09.010","article-title":"Complicated urinary tract infections","volume":"35","author":"Neal","year":"2008","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.clinthera.2012.05.002_bib17","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/jac\/dkq363","article-title":"Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase","volume":"65","author":"Poulou","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib18","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.00102-11","article-title":"Dissemination of clinical isolates of Klebsiella oxytoca harboring CMY-31, VIM-1, and a new OXY-2 type variant in the community","volume":"55","author":"Tsakris","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jac\/dkn547","article-title":"Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA","volume":"63","author":"Endimiani","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1086\/592412","article-title":"Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies","volume":"29","author":"Patel","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"30","author":"Gasink","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib22","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/AAC.01020-07","article-title":"Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality","volume":"52","author":"Schwaber","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib23","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jac\/dkm356","article-title":"Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study","volume":"60","author":"Falagas","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2012.05.002_bib25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1086\/657135","article-title":"Bloodstream infections caused by metallo-\u03b2-lactamase\/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes","volume":"31","author":"Mouloudi","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.clinthera.2012.05.002_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/dkm193","article-title":"Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials","volume":"60","author":"Vidal","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/jac\/dkq108","article-title":"Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection","volume":"65","author":"Hirsch","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/mdr.2009.0031","article-title":"Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae","volume":"16","author":"Castanheira","year":"2010","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.clinthera.2012.05.002_bib29","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dkq116","article-title":"Should tigecycline be considered for urinary tract infections?","volume":"65","author":"Nix","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijantimicag.2011.01.012","article-title":"What remains against carbapenem-resistant Enterobacteriaceae?","volume":"37","author":"Livermore","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2012.05.002_bib31","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2012.05.002_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812003207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812003207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:46Z","timestamp":1758962926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812003207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0149291812003207"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.05.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment and Clinical Outcomes of Urinary Tract Infections Caused by KPC-Producing Enterobacteriaceae in a Retrospective Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}